To the Editor: It was with interest that we read the recent article by Cheng et al. published in Supportive Care in Cancer [1]. The study highlighted very well the importance of understanding patient’s subjective constipation experiences as little correlation was observed in this work between people’s reports, the frequency with which bowels were opened, and the stool form. Reporting stool form requires greater exploration as recording this information has been recommended as an aid to titrating laxatives. Observation charts such as the Bristol Stool Chart have been suggested to provide guidance to patients and health professionals [2]. This is based on previous observations that have identified stool form as a way to predict colon transit time [3]. However, this work was undertaken in a healthy population. Scant attention so far paid to understanding how such observations could be extrapolated to people with cancer who are likely to have several contributing factors for disturbed bowel habits occurring simultaneously. Recent work by Dinning et al. is relevant to consider [4]. The aim of this work was to objectively assess the effects of laxatives on people’s constipation symptoms. This included a review of people’s stool form charts (n094) all of whom had scintigraphically confirmed functional slow transit (>72 h). Eighty percent of this cohort were taking laxatives either daily (n028) or intermittently (n049). The results showed that despite proven slow transit constipation, people continued to pass soft to lose frequent stools whilst taking laxatives with 75 % of the people studied falling into the normal bowel habit category (i.e. passing a bowel action more than three times per week or more than every 3 days). However, subjects self-reported severe symptoms related to pain, bloating and a need to strain when attempting to pass a bowel motion. The main conclusion of this work was that whilst laxatives aid defecation in non-cancer populations with functional constipation, these medications have little effect to improve self-reported symptoms. More work is needed as it is likely that the underlying problems experienced by people with cancer are more complex than just functional slow transit constipation. Cancer patients are exposed to many other factors that could contribute to slow colonic transit including medications, reduced functional status, impaired appetite and electrolyte disturbances. They are also at high risk of developing problems that could hinder normal defecation such as muscle wasting of the pelvic floor [5]. There is a real need to try and classify cancer patients with constipation according to the underlying problems (pre-existing bowel dysfunction, slow transit and problems of defecation). This work requires well-tolerated and easy to perform physiological function tests of colon transit and defecation. Until such work is undertaken, it remains difficult to understand the optimal approaches to assessing and palliating bowel problems. K. Clark (*) Department of Palliative Care, Calvary Mater Newcastle, Edith St., Waratah, NSW 2298, Australia e-mail: Katherine.Clark@calvarymater.org.au
Read full abstract